Assay identifies rare tick-borne bacteria: Bobbi Pritt, M.D.
Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Bobbi Pritt, M.D., explains how Mayo Clinic Laboratories' new assay identifies less-common tick-borne bacteria in whole blood. The assay is recommended when tick-borne bacterial infection is suspected but standard testing is unrevealing.
(00:33)
Do you mind giving us a brief introduction of yourself and what you do at Mayo?
(01:45)
Can you tell us a little about the test and how it came to be?
(03:00)
Could you explain the types of patients this test would be best suited for and how a provider might determine if their patient would benefit from this?
(03:32)
Would you please explain why the algorithm is recommended and where in the algorithm this test fits?
(04:36)
What makes this test different from what's currently available to providers?
(05:38)
How can the information be used in patient care? And can you talk a little bit about how the diagnosis can be clarified by using this assay, why it's important, and how the results would impact a patient's care and treatment plan?